[1]
R. C. Reuben e L. Y. Adogo, “SARS-CoV-2 vaccines–induced thrombotic thrombocytopenia: should we consider immuno-hypersensitivity?”,
Rev. saúde pública
, vol. 55, p. 70, out. 2021,
doi: 10.11606/s1518-8787.2021055003855.